Business · 20/08/2012Updated: 10/17/2026 · 1 min read
Hospira, Inc. Seeks FDA Approval Withdrawal for DEXTRAN 70
Summary
Hospira, Inc. has requested the FDA to withdraw its approval of a new drug application for DEXTRAN 70, a medication no longer marketed by the company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →